Latest Middle East News

EPX Limited has landed a significant seven-year contract worth over A$5 million to deploy its EDGE technology across 10 healthcare facilities in the UAE, aiming to boost energy efficiency and sustainability.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

SunRice reported steady FY25 financials with improved profitability despite revenue pressure, while advancing its 2030 Growth Strategy amid industry headwinds and leadership transition.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

First Graphene Limited reveals significant progress in commercialising its PureGRAPH graphene technology, highlighting expanding global partnerships and a robust sales pipeline valued over A$10 million.

ClearVue Technologies has announced a comprehensive strategic reset following a Kidder Williams review, including a refreshed board, significant cost savings, and a renewed focus on growth markets in Australia, Asia, and the Middle East.

Canyon Resources has confirmed its Minim Martap Bauxite Project in Cameroon as a world-class, tier-one operation with production set to begin in early 2026. The project boasts over 1 billion tonnes of high-grade bauxite, strong economics, and secured financing.

ClearVue Technologies reported a striking 553% revenue increase to nearly $250,000 in FY2025, alongside a 7% reduction in net loss, driven by strategic partnerships and global project wins.

My Rewards International Limited reports a 47% revenue drop but narrows losses by 45%, fueled by strategic acquisition and tech innovation. The company advances ASX reinstatement with a capital raise and debt conversion plan.

Streamplay Studio’s FY25 preliminary results reveal a striking 121% income surge, driven by the strategic acquisition of North American game studio Noodlecake, positioning the company for a $10 million annual income trajectory.

Streamplay Studio Limited reported a remarkable 201% surge in operating revenue for FY25, driven by its strategic acquisition of Noodlecake Studios and expansion into new markets. Despite a wider operating loss, the company achieved positive cash flow and profitability in the final quarter, signaling a promising turnaround.